NVS vs SRRK
Novartis AG vs Scholar Rock Holding Corporation — AI-powered side-by-side comparison
VS
SRRK
Scholar Rock Holding Corporation
57
Watch
| Metric | NVS | SRRK |
| AI Score |
75
|
57
|
| Price |
$154.64
|
$52.11
|
| P/E Ratio |
23.55×
|
-15.73×
|
| ROE |
30.5%
|
-154.0%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
74.3%
|
0.0%
|
| Debt / Equity |
1.18×
|
0.80×
|
| Dividend Yield |
2.9%
|
0.0%
|
| RSI (14) |
57.7
|
60.3
|
| Beta |
0.462
|
0.666
|
| Expected Upside |
+2.4%
|
—
|
AI Committee View
Current Innellis committee reasoning for NVS versus SRRK.
NVS leads by 18 points.
NVS scores 75/100 (Buy) versus SRRK at 57/100 (Watch).
NVS Committee View
100% agreement
5 analysts
The primary driver is quarter-over-quarter growth rate is accelerating, not just positive. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
Bear Case
- MACD histogram negative -- bearish momentum — Technical
SRRK Committee View
60% agreement
5 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Risk Analyst remains cautious — bollinger bandwidth of 18.2% signals elevated volatility. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Price-to-book of 18.3x prices in significant intangible value — Value
- ROE of only -159.1% -- cheap may mean cheap for a reason — Value
- Bollinger bandwidth of 18.2% signals elevated volatility — Risk